Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

Rhea-AI Summary

Rapid Micro Biosystems, Inc. (RPID) will release its Q4 and full-year 2023 financial results on March 1, 2024. The company offers automation solutions for healthcare product manufacturing.

LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, March 1, 2024. The live webcast will be accessible on the Company’s website here and will be available for replay for one year from the webcast date.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct System automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct System brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Lexington, Massachusetts, Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the company on Twitter at @rapidmicrobio or on LinkedIn.

FAQ

When will Rapid Micro Biosystems release its Q4 and full-year 2023 financial results?

Rapid Micro Biosystems will release its Q4 and full-year 2023 financial results on March 1, 2024.

What does Rapid Micro Biosystems specialize in?

Rapid Micro Biosystems specializes in providing automation solutions for the manufacturing of healthcare products.

Where can I access the webcast conference call hosted by Rapid Micro Biosystems?

The webcast conference call hosted by Rapid Micro Biosystems can be accessed on the company's website.

How long will the webcast be available for replay?

The webcast will be available for replay for one year from the webcast date.